Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Naegelen

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|April 30, 2013
[Prevention of bacterial risk: pathogen inactivation/detection of bacteria]P Morel, C Naegelen, M Deschaseaux, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|May 19, 2009
[Automation in the preparation of labile blood products]R Tardivel, S Bois, C Vignoli, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|June 12, 2003
[Transfusion-transmitted bacterial infection: residual risk and perspectives of prevention]P Morel, M Deschaseaux, X Bertrand, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|December 10, 2002
[Detection of bacterial contamination in platelet concentrates: perspectives]P Morel, M Deschaseaux, X Bertrand, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|October 28, 1998
[Surveillance of biocontamination of the environment of labile blood products: its role in a quality assurance program]P Morel, C Naegelen, M Masse, et al.
Transfusion|July 1, 1992
Validation of a simple method to count very low white cell concentrations in filtered red cells or plateletsM Masse, C Naegelen, N Pellegrini, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|April 30, 2013
[Control of the bacterial risk of transfusion in France in 2013]P Morel, M Deschaseaux, X Bertrand, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|May 17, 2005
[Bacterial detection leading to pathogen inactivation]P Morel, M Deschaseaux, C Naegelen, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|May 16, 2009
[Evolution of techniques for preparation of labile blood products (LBP): pathogen inactivation in LBP]C Naegelen, H Isola, D Dernis, et al.
Vox Sanguinis|May 22, 2003
Quality assessment of seven types of fresh-frozen plasma leucoreduced by specific plasma filtrationA Chabanel, I Sensebé, M Masse, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|April 30, 2013
[Prevention of bacterial risk: pathogen inactivation/detection of bacteria]P Morel, C Naegelen, M Deschaseaux, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|May 19, 2009
[Automation in the preparation of labile blood products]R Tardivel, S Bois, C Vignoli, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|June 12, 2003
[Transfusion-transmitted bacterial infection: residual risk and perspectives of prevention]P Morel, M Deschaseaux, X Bertrand, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|December 10, 2002
[Detection of bacterial contamination in platelet concentrates: perspectives]P Morel, M Deschaseaux, X Bertrand, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|October 28, 1998
[Surveillance of biocontamination of the environment of labile blood products: its role in a quality assurance program]P Morel, C Naegelen, M Masse, et al.
Transfusion|July 1, 1992
Validation of a simple method to count very low white cell concentrations in filtered red cells or plateletsM Masse, C Naegelen, N Pellegrini, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|April 30, 2013
[Control of the bacterial risk of transfusion in France in 2013]P Morel, M Deschaseaux, X Bertrand, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|May 17, 2005
[Bacterial detection leading to pathogen inactivation]P Morel, M Deschaseaux, C Naegelen, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|May 16, 2009
[Evolution of techniques for preparation of labile blood products (LBP): pathogen inactivation in LBP]C Naegelen, H Isola, D Dernis, et al.
Vox Sanguinis|May 22, 2003
Quality assessment of seven types of fresh-frozen plasma leucoreduced by specific plasma filtrationA Chabanel, I Sensebé, M Masse, et al.
Pageof 2